Cytokinetics Inc. buy Barclays PLC
Start price
03.09.25
/
50%
€41.60
Target price
03.09.26
€61.04
Performance (%)
31.01%
Price
20.01.26
€54.50
Summary
This prediction is currently active. With a performance of 31.01% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 03.09.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 0.000% | 0.000% |
| iShares Core DAX® | -3.141% | 1.269% |
| iShares Nasdaq 100 | -3.518% | -1.355% |
| iShares Nikkei 225® | -3.396% | 3.283% |
| iShares S&P 500 | -2.943% | -0.533% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Barclays PLC from $53.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
87.93%
20.01.26
20.01.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
62.20%
20.01.26
20.01.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25